Asustek Computer Inc (華碩) yesterday launched its new Transformer Book Chi series as part of an effort to double shipments of its two-in-one detachable devices to 6 million units this year, a company executive said yesterday.
“As of recently, our Transformer Book T100 launched in October 2013 has shipped more than 3 million units and we have confidence that the shipment of the new Transformer Book Chi series will outperform T100’s record,” Asustek chief executive officer Jerry Shen (沈振來) said at the product launch in Taipei.
Shen said the Transformer Book T100 served as a key growth driver for the company last year, adding that not only did the product make impressive sales, it also accounted for 20 percent of the firm’s total revenue.
“We hope the revenue of tablet-notebook hybrid devices will increase by 20 percent to 30 percent this year, with the launch of the new Transformer Book Chi series product line,” Shen said.
Asustek also launched two new ZenBook models — Asus ZenBook UX305 and ZenBook Pro UX501.
Shen said the functionality and efficiency of the two models are better than rival Apple Inc’s MacBook Pro.
Shen said he nicknamed the 15.6-inch ZenBook Pro UX501 a “high-performance monster,” as the product is 2.06cm thick, but has an ultra-high-resolution — or 4K — display with an Intel Core i7 processor and gaming-grade graphics.
Asustek is upbeat that its PC segment will put up a strong performance this year, driven by sales of the new two-in-one devices, the ZenBook series, its Chromebook and its low-cost EeeBook, Shen said.
The company is set to launch a new Chromebook in the next quarter, Shen added.
Asustek’s goal is to achieve 15 percent growth in PC-related product shipments every year and to double PC-related product shipments within five years, Shen said.
According to market researcher TrendForce’s latest report, Asustek’s notebook shipments accounted for 11 percent of the market, or 19.3 million units, last year, ranking it fourth in terms of global notebook shipments, beating its rival Acer Inc (宏碁).
Separately, Shen said chipmaker Qualcomm being fined US$975 million by the Chinese government for violating antimonopoly laws is positive news for Asustek.
However, he declined to comment further on the news for the time being, saying that he would talk more about it at an investors’ conference set for Friday.
Asustek’s smartphone brand Pegasus, which launched a smartphone in China last month, uses Qualcomm’s processor.
JPMorgan Chase & Co chief executive officer Jamie Dimon on Tuesday quipped that his company is likely to outlast the Chinese Communist Party (CCP), while reiterating the bank’s commitment to the country in wide-ranging comments that also touched on Taiwan, free speech and former US president Donald Trump. “We hope to be there [in China] for a long time,” Dimon told a panel discussion at the Boston College Chief Executives Club. Relaying a “joke” he made during a recent visit to Hong Kong, he said “The communist party is celebrating its 100th year. So is JPMorgan. And I’ll make you a
The Kaohsiung City Government yesterday said it would impose a property hoarding tax as it is seeking to contain speculation in the real-estate market, calling recent price increases “abnormal.” The announcement came in support of the Ministry of Finance’s call for local governments to levy a high tax rate on people with more than one property. Ministry officials on Tuesday discussed strategies to rein in speculation with the nation’s six special municipalities, as well as the Hsinchu city and county governments. About 84,000 out of 1.06 million housing units in Kaohsiung are not residential property, the city government said in a
BOOST EXPECTED: Higher market prices would offset effects of the industry’s transition to more climate-friendly production methods, a company official said China Steel Corp (CSC, 中鋼) expects steel demand to increase on the back of governments around the world subsidizing infrastructure construction amid a stabilizing COVID-19 pandemic, CSC chairman Wong Chao-tung (翁朝棟) told an investors’ meeting yesterday. “After getting through the hard times, I foresee at least one year, very possibly two years, of strong steel market,” Wong said. Calling a dip in steel prices a “short respite for the market,” Wong said that it would likely bounce back early next year on the back of mild winter temperatures around the world allowing construction activity. Despite COVID-19 spikes in some regions and increased
PharmaEssentia Corp (藥華醫藥) shares have jumped 80.56 percent since the company obtained a US polycythemia vera (PV) drug license for its new interferon drug Besremi (ropeginterferon alfa-2b-njft) on Nov. 12. Shares on Friday closed at NT$195 in Taipei trading, up from the stock’s closing price of NT$108 on Nov. 12. PV is a rare, chronic and life-threatening blood cancer linked to a stem cell mutation in the bone marrow that results in an overproduction of blood cells and places sufferers at risk of having a blood clot, stroke or heart attack. PharmaEssentia is preparing to make Besremi available in the US in the